Lee YH - Search Results

1

Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Lee YH, Hsu CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Huo TI, Lee SD. Lee YH, et al. Among authors: lee rc, lee sd. J Gastroenterol Hepatol. 2012 Oct;27(10):1581-8. doi: 10.1111/j.1440-1746.2012.07151.x. J Gastroenterol Hepatol. 2012. PMID: 22497632

2

Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systems.

Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Loong CC, Chiou YY, Huo TI. Lee YH, et al. Dig Liver Dis. 2012 Oct;44(10):868-74. doi: 10.1016/j.dld.2012.04.018. Epub 2012 May 28. Dig Liver Dis. 2012. PMID: 22647396

3

Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system.

Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI. Hsu CY, et al. Among authors: lee yh, lee rc, lee fy. Hepatology. 2013 Jan;57(1):112-9. doi: 10.1002/hep.25950. Hepatology. 2013. PMID: 22806819

4

α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.

Lee YH, Hsu CY, Huang YH, Su CW, Lin HC, Hsia CY, Huo TI. Lee YH, et al. J Gastrointest Surg. 2013 Apr;17(4):730-8. doi: 10.1007/s11605-012-2081-5. Epub 2012 Nov 28. J Gastrointest Surg. 2013. PMID: 23188220

5

Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?

Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Huo TI. Lee YH, et al. Among authors: lee rc. J Gastroenterol Hepatol. 2013 Feb;28(2):348-56. doi: 10.1111/jgh.12062. J Gastroenterol Hepatol. 2013. PMID: 23190248

6

Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria.

Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Chiou YY, Lee FY, Huo TI. Hsu CY, et al. Among authors: lee yh, lee fy. Ann Surg Oncol. 2013 Jun;20(6):2035-42. doi: 10.1245/s10434-012-2847-8. Epub 2013 Jan 11. Ann Surg Oncol. 2013. PMID: 23306955

7

Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.

Lee YH, Hsia CY, Hsu CY, Huang YH, Lin HC, Huo TI. Lee YH, et al. World J Surg. 2013 Jun;37(6):1348-55. doi: 10.1007/s00268-013-1978-9. World J Surg. 2013. PMID: 23467925

8

Assessing liver dysfunction in cirrhosis: role of the model for end-stage liver disease and its derived systems.

Lee YH, Hsu CY, Huo TI. Lee YH, et al. J Chin Med Assoc. 2013 Aug;76(8):419-24. doi: 10.1016/j.jcma.2013.04.010. Epub 2013 Jun 5. J Chin Med Assoc. 2013. PMID: 23746532 Free article. Review.

9

Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact.

Lee YH, Hsu CY, Huang YH, Hsia CY, Chiou YY, Su CW, Lin HC, Huo TI. Lee YH, et al. J Clin Gastroenterol. 2014 Sep;48(8):734-41. doi: 10.1097/MCG.0b013e3182a8a254. J Clin Gastroenterol. 2014. PMID: 24100755

10

Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.

Liu PH, Lee YH, Hsia CY, Hsu CY, Huang YH, Chiou YY, Lin HC, Huo TI. Liu PH, et al. Among authors: lee yh. Ann Surg Oncol. 2014 Jun;21(6):1825-33. doi: 10.1245/s10434-014-3510-3. Epub 2014 Feb 6. Ann Surg Oncol. 2014. PMID: 24499831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,531 results

Search Page

Filters